Clinical Trial Update: Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial investigating the role of gut microbiota in managing immune thrombocytopenia, sponsored by Shandong University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia | Phase 2 | Status: UNKNOWN